Objective To study characteristics of PLA sustained release nanoparticle(nps) incorporating Isoniazid(INH) and Rifampicin(RFP) through release in vitro,in order to provide new targeted carrier of anti-tuberculosis chemotherapy.Methods⑴INH-RFP-PLA-NPS using modified spontaneous emulsification solvent diffusion method and stored by freeze-dried.⑵The submicron particle size analyzer was used to determine the nanoparticle size and distribution,observing the morphology of nanoparticle with Transmission Electron Microscope.⑶High Performance Liquid Chromatography(HPLC) was used to construct method of determination and determine drug loading(DL) and entrapment efficiency(EE) .⑷Phosphate buffer solution(PBS) was used as a medium to study the characteristics of release in vitro of INH-RFP-PLA-NPS.Results⑴The morphology and nanoparticle of INH-RFP-PLA-NPS were smooth and uniform ,no obvious adhesive phenomena.⑵The submicron particle size analyzer was used to determine nanoparticle size and distribution, the mean diameter was 80.4nm and distribution uniform.⑶The drug loading and entrapment efficiency of INH were 15.95±1.34(%)and 5.01±0.17(%), RFP were 4.66±0.97(%) and 4.05±0.18(%),respectively.⑷Release in vitro,the result of INH-RFP-PLA-NPS was good,the rate of INH was 15.22% in burst release phrase, and rose to 95.6% after 3 days, RFP was 9.26% and rose to 90.3% after 3 days.Conclusions⑴INH-RFP-PLA-NPS using modified spontaneous binary solvent diffusion method, the mean diameter were small and uniform.⑵Release in vitro of INH-RFP-PLA-NPS was stable, no obvious burst release phenomena. |